Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2013

Nov 18, 2013

30786_dirs_2013-11-18_bd099b5d-bf5a-41a8-8ad9-24f31571e410.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2013-11-15

Reporting Person: SCHWARTZ NORMAN D (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-15 Bio-Rad B Common Stock M 62421 $53.50 Acquired 190904 Direct
2013-11-15 Bio-Rad B Common Stock F 45529 $123.24 Disposed 145375 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-15 Non-Qualified Stock Option (right to buy) $53.50 M 62421 Disposed 2014-02-04 Bio-Rad B Common Stock (62421) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12266 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The shares are held by a limited partnership of which the reporting person is a limited partner.

F4: The option vested in five equal annual installments beginning on February 4, 2005.